Modelling new enhancing MRI lesion counts in multiple sclerosis

Abstract

Magnetic resonance imaging (MRI) has been established as the most relevant paraclinical tool for diagnosing and monitoring multiple sclerosis (MS). In this context, counting the number of new enhancing lesions on monthly MRI scans is widely used as a surrogate marker of MS activity when evaluating the effect of treatments. In this study, we investigated whether parametric models based on mixed Poisson distributions (the Negative Binomial (NB) and the Poisson-Inverse Gaussian (P-IG) distributions) were able to provide adequate fitting of new enhancing lesion counts in MS. We found that the NB model gave good approximations in relapsing7remitting and secondary progressive MS patients not selected for baseline MRI activity, whereas the P-IG distribution modelled better new enhancing lesion counts in relapsing-remitting MS patients selected for baseline activity. This study shows that parametric modelling for MS new enhancing lesion counts is feasible. This approach should provide more targeted tools for the design and the analysis of MRI monitored clinical trials in MS.

Keywords

multiple sclerosis magnetic resonance imaging mixed poisson distributions

Get full access to this article

View all access options for this article.

References

Miller DH et al. (1996) Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis . Ann Neurol 39: 6-16 .

Rovaris M , Filippi M. (1999) Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis . Curr Opin Neurol 12: 337-344 .

Katz D et al. (1993) Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis . Ann Neurol 34: 661-669 .

McFarland HF et al. (1992) Using gadolinium-enhanced magnetic resonance imaging to monitor disease activity in multiple sclerosis . Ann Neurol 32: 758-766 .

Miller DH et al. (1991) Magnetic resonance imaging in monitoring the treatment of multiple sclerosis. Concerted Action Guidelines . J Neurol Neurosurg Psychiatry 54: 683-688 .

Miller DH , Barkhof F , Nauta JJP. (1993) Gadolinium enhancement increased the sensitivity of MRI in detecting disease activity in MS . Brain 116: 1077-1094 .

Gardner W , Mulvey EP , Shaw EC. (1995) Regression analysis of counts and rates, Poisson, overdispersed Poisson, and negative binomial models . Psychol Bull 118: 392-404 .

Kault D. (1996) The shape of the distribution of the number of sexual partners . Stat Med 15: 221-230 .

Hougaard P , Ting Lee ML , Whitmore GA. (1997) Analysis of overdispersed count data by mixtures of Poisson variables and Poisson processes . Biometrics 53: 1225-1238 .

10.

Willmot GE. (1987) The Poisson-Inverse Gaussian as an alternative to the Negative Binomial . Scand Actuarial J 87: 113-127 .

11.

Ord J , Whitmore G. (1986) The Poisson-Inverse Gaussian distribution as a model for species abundance. Communication in Statistics A . Theory and Methods 15: 853-871 .

12.

Sichel HS. (1974) On a distribution representing sentence-length in written prose . J Roy Stat Soc 137: 25-34 .

13.

Sormani MP et al. (1999) Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials . JNeurol Sci 163: 74-80 .

14.

Nauta JJP , Thompson AJ , Barkhof F , Miller DH. (1994) Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients, statistical power of parallel-groups and crossover designs . J Neurol Sci 122: 6-14 .

15.

Truyen L et al. (1997) Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS), implications for phase II therapeutic trials . Mult Scler 2: 283-290 .

16.

Tubridy N et al. (1998) Exploratory treatment trials in multiple sclerosis using MRI, sample size calculations for relapsing remitting and secondary progressive subgroups using placebo controlled parallel groups . JNeurol Neurosurg Psychiatry 64: 50-55 .

17.

Sormani MP et al. (1999) Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results . J Neurol Neurosurg Psychiatry 66: 465-469 .

18.

Filippi M et al. (1999) Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI . Neurology 52: 588-594 .

19.

Tortorella C et al. (2000) A magnetization transfer histogram study of normal appearing brain tissue in multiple sclerosis . Neurology 54: 186-193 .

20.

Comi G , Filippi M , Wolinsky SJ and the European/Canadian Glatiramer Acetate Study Group . (2001) Europen/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease acrivity and burden in patients with relapsing multiple sclerosis . Ann Neurol 49: 290-297 .

21.

Miller DH et al. (1999) Effect of interferon b-1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis. Results of a European multicenter, randomized, double-blind, placebo-controlled trial . Ann Neurol 46: 850-859 .

22.

Tubridy N et al. (1999) The effect of anti-alpha4 integrin antibody on brain lesion activity in MS . Neurology 53: 466-472 .

23.

Kurtzke J. (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

24.

Lawless JF. (1987) Negative binomial and mixed Poisson regression . Can J Stat 15: 209-225 .

25.

Venables WN , Ripley BD. (1994) Modern applied statistics with S-Plus. Springer-Verlag: New York .

26.

Albert PS et al. (1994) Repeated measures. Time series for modelling counts from a relapsing-remitting disease, application to modelling disease activity in multiple sclerosis . Stat Med 13: 453-466 .

27.

Bagnato F et al. (2000) Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis: a short term natural history study . Mult Scler 6: 43-49 .

28.

McCullogh P , Nelder JA. (1989) Generalized linear models. Chapman and Hall: New York .